Uma P. Giri

5.4k citations

53 papers · 4.4k · 3 hit papers · h-index 27

Impact in

Cancer Research top 2%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Oncology top 2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis

Papers in

Cancer Research 11
- Cancer Genomics and Diagnostics 4
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 3
Oncology 12
- Cancer-related Molecular Pathways 4

Co-authors: Mohammad S. Athar (6 shared papers)John Victor Heymach (17 shared papers)Mohammad Iqbal (3 shared papers)Michael D. Story (11 shared papers)John S. Yordy (4 shared papers)Heath Devin Skinner (3 shared papers)Jeffrey Myers (3 shared papers)Beth Michelle Beadle (3 shared papers)
Journals: Clinical Cancer Research (11 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)Cancer Research (3 papers)Cancer Discovery (2 papers)Biochemical and Biophysical Research Communications (2 papers)
Partner nations: United States India China

In The Last Decade

Uma P. Giri

51 papers receiving 4.3k citations

Uma P. Giri's Hit Papers

align trajectories log scale

Co-occurring Genomic Alterations Define Major Subsets of KRAS -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities 2015 · 770 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2015 Cancer Discovery
2015 Clinical Cancer Research
2012 Clinical Cancer Research

Peers

Countries citing papers authored by Uma P. Giri

Since Specialization

Citations

This map shows the geographic impact of Uma P. Giri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uma P. Giri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uma P. Giri more than expected).

Fields of papers citing papers by Uma P. Giri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uma P. Giri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uma P. Giri. The network helps show where Uma P. Giri may publish in the future.

Co-authors

The 25 scholars most cited alongside Uma P. Giri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Uma P. Giri Line = papers co-authored together Uma P. Giri links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance Clinical Cancer Research ·Lauren Byers, Lixia Diao, Jing Wang, Pierre Saintigny, Luc Girard, Michael Peyton, Li Shen, You-Hong Fan Hit paper breakdown →	2012	850
2	Co-occurring Genomic Alterations Define Major Subsets of KRAS -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities Cancer Discovery ·Ferdinandos Skoulidis, Lauren Byers, Lixia Diao, Vassiliki A. Papadimitrakopoulou, Pan Tong, Julie G. Izzo, Carmen Behrens, Humam N. Kadara Hit paper breakdown →	2015	770
3	Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1 Cancer Discovery ·Lauren Byers, Jing Wang, Monique B. Nilsson, Junya Fujimoto, Pierre Saintigny, John S. Yordy, Uma P. Giri, Michael Peyton	2012	451
4	Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses Clinical Cancer Research ·Tilak Kumar Sundaresan, Lecia Van Dam Sequist, John Victor Heymach, Gregory J. Riely, Pasi Antero Janne, Walter H Koch, James P. Sullivan, Douglas B. Fox Hit paper breakdown →	2015	321
5	TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence Clinical Cancer Research ·Heath Devin Skinner, Vlad Constantin Sandulache, Thomas Julian Ow, Raymond E. Meyn, John S. Yordy, Beth Michelle Beadle, Alison L. Fitzgerald, Uma P. Giri	2011	248
6	KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling Journal of Clinical Investigation ·Klaus W. Wagner, Hunain Alam, Shilpa S. Dhar, Uma P. Giri, Na Li, Yongkun Wei, Dipak Kumar Giri, Tina Cascone	2013	163
7	Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer Cancer Research ·David M. Neskey, Abdullah A. Osman, Thomas Julian Ow, Panagiotis Katsonis, Thomas O. McDonald, Stephanie C. Hicks, Teng‐Kuei Hsu, Curtis R. Pickering	2015	138
8	miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue Head & Neck ·Latha Ramdas, Uma P. Giri, Cheryl L. Ashorn, Kevin R. Coombes, Adel K. El‐Naggar, K. Kian Ang, Michael D. Story	2009	126
9	Porphyrin-mediated photosensitization has a weak tumor promoting activity in mouse skin: possible role of in situ-generated reactive oxygen species Carcinogenesis ·Uma P. Giri, Mohammad Iqbal, Mohammad S. Athar	1996	112
10	Integrative Analysis Identifies a Novel AXL–PI3 Kinase–PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer Clinical Cancer Research ·Heath Devin Skinner, Uma P. Giri, Liang Peng Yang, Manish Kumar, Ying Liu, Michael D. Story, Curtis R. Pickering, Lauren Byers	2017	104
11	DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy Clinical Cancer Research ·Benjamin J. Moeller, John S. Yordy, Michelle D. Williams, Uma P. Giri, Uma Raju, David P. Molkentine, Lauren Byers, John Victor Heymach	2011	79
12	Ferric Nitrilotriacetate (Fe-NTA) Is a Potent Hepatic Tumor Promoter and Acts Through the Generation of Oxidative Stress Biochemical and Biophysical Research Communications ·Muzaffar Iqbal, Uma P. Giri, Mohammad S. Athar	1995	71
13	STK11 /LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition Clinical Cancer Research ·Piyada Sitthideatphaiboon, Ana Galán‐Cobo, Marcelo Vailati Negrao, Xiao Qu, Alissa Poteete, Fahao Zhang, Diane D. Liu, Whitney E. Lewis	2020	69
14	The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non–Small Cell Lung Cancer Clinical Cancer Research ·Tina Cascone, Li Xu, Heather Yan Lin, Wenbin Liu, Hai T. Tran, Yuan Liu, Kathryn Howells, Vincent Haddad	2017	68
15	Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer Clinical Cancer Research ·Heath Devin Skinner, Uma P. Giri, Liang Peng Yang, Sang Hyeok Woo, Michael D. Story, Curtis R. Pickering, Lauren Byers, Michelle D. Williams	2016	66
16	In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation Molecular Therapy — Nucleic Acids ·María Angélica Cortez, David R. Valdecanas, Sharareh Niknam, Heidi J. Peltier, Lixia Diao, Uma P. Giri, Ritsuko U Komaki, George A. Călin	2015	65
17	Evidence That in Situ Generated Reactive Oxygen Species Act as a Potent Stage I Tumor Promoter in Mouse Skin Biochemical and Biophysical Research Communications ·Uma P. Giri, Sonia Sharma, Mahmood Ameen Abdulla, Mohammad S. Athar	1995	63
18	Increased VEGFR-2 Gene Copy Is Associated with Chemoresistance and Shorter Survival in Patients with Non–Small-Cell Lung Carcinoma Who Receive Adjuvant Chemotherapy Cancer Research ·Fei Yang, Ximing Tang, Erick Marcelo Riquelme, Carmen Behrens, Monique B. Nilsson, Uma P. Giri, Marileila Varella‐Garcia, Lauren Byers	2011	55
19	Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial–mesenchymal transition BMC Genomics ·Steven Hsesheng Lin, Jing Wang, Pierre Saintigny, Chia-Chin Wu, Uma P. Giri, Jing Zhang, Toshi Menju, Lixia Diao	2014	47
20	Age-Dependent Renal Accumulation of 4-Hydroxy-2- Nonenal (HNE)-Modified Proteins Following Parenteral Administration of Ferric Nitrilotriacetate Commensurate with Its Differential Toxicity: Implications for the Involvement of HNE–Protein Adducts in Oxidative Stress and Carcinogenesis Archives of Biochemistry and Biophysics ·Mohammad Iqbal, Uma P. Giri, Dipak K. Giri, M. S. Alam, Mohammad Athar Mehraj	1999	46

About Uma P. Giri

Uma P. Giri is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Biochemistry, having authored 53 papers that have together received 4.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer-related Molecular Pathways (4 papers), MicroRNA in disease regulation (4 papers), Nanoplatforms for cancer theranostics (3 papers), Photodynamic Therapy Research Studies (3 papers), Autophagy in Disease and Therapy (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.8k citations), Otorhinolaryngology (167 citations), Pulmonary and Respiratory Medicine (1.1k citations) and Molecular Biology (2.0k citations). Uma P. Giri has collaborated with scholars based in United States, India and China. Frequent co-authors include Mohammad S. Athar, John Victor Heymach, Mohammad Iqbal, Michael D. Story, John S. Yordy, Heath Devin Skinner, Jeffrey Myers, Beth Michelle Beadle, Raymond E. Meyn and Kevin R. Coombes. Their work appears in journals such as Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics, Cancer Research, Cancer Discovery and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Uma P. Giri

Impact in

Papers in i

In The Last Decade

Uma P. Giri

Uma P. Giri's Hit Papers

Peers

Countries citing papers authored by Uma P. Giri

Fields of papers citing papers by Uma P. Giri

All Works

About Uma P. Giri

Explore authors with similar magnitude of impact

Papers in